98 related articles for article (PubMed ID: 6190363)
1. Interaction of plasma kallikrein with plasma proteinase inhibitors.
Salvesen G; Virca GD; Travis J
Adv Exp Med Biol; 1983; 156():121-30. PubMed ID: 6190363
[No Abstract] [Full Text] [Related]
2. Role of high molecular weight kininogen in modulating the inactivation of human plasma kallikrein by plasma protease inhibitors.
Schapira M; James A; Scott CF; Kueppers F; James HL; Cohen AB; Colman RW
Adv Exp Med Biol; 1983; 156():131-41. PubMed ID: 6190364
[No Abstract] [Full Text] [Related]
3. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
Heeb MJ; España F
Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
[TBL] [Abstract][Full Text] [Related]
4. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
Olson ST; Sheffer R; Francis AM
Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
[TBL] [Abstract][Full Text] [Related]
5. Prekallikrein activation and kallikrein inactivation in human plasma.
van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
[No Abstract] [Full Text] [Related]
6. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
Gallimore MJ; Friberger P
Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
[No Abstract] [Full Text] [Related]
7. Inactivation of kallikrein in human plasma.
van der Graaf F; Koedam JA; Bouma BN
J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
[TBL] [Abstract][Full Text] [Related]
8. Significance of the regulation of plasma kallikrein by alpha 2M.
Colman RW
Ann N Y Acad Sci; 1994 Sep; 737():347-67. PubMed ID: 7524407
[No Abstract] [Full Text] [Related]
9. Binding of a monoclonal anti-human plasma prekallikrein antibody to the complexes of kallikrein with C1-inhibitor and alpha 2-macroglobulin analyzed by immunoblot and "sandwich" assays.
Veloso D; Tseng SY; Craig AR; Colman RW
Adv Exp Med Biol; 1989; 247A():499-505. PubMed ID: 2481391
[No Abstract] [Full Text] [Related]
10. C1 inhibitor: the predominant inhibitor of plasma kallikrein.
Schapira M; de Agostini A; Colman RW
Methods Enzymol; 1988; 163():179-85. PubMed ID: 3237074
[No Abstract] [Full Text] [Related]
11. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.
Schapira M; Scott CF; Colman RW
J Clin Invest; 1982 Feb; 69(2):462-8. PubMed ID: 6173399
[TBL] [Abstract][Full Text] [Related]
12. C1 inhibitor: the main inhibitor of human plasma kallikrein.
Trumpi-Kalshoven MM; Kluft C
Adv Biosci; 1978 Jul; 17():93-101. PubMed ID: 90628
[No Abstract] [Full Text] [Related]
13. A rapid method for functional determination of C1 esterase inhibitor in plasma.
Cullmann W; Kövary PM; Dick W; Czarnetzki B; Echternach-Happle K
Clin Chim Acta; 1982 Mar; 119(3):237-42. PubMed ID: 6175450
[TBL] [Abstract][Full Text] [Related]
14. High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors.
Schapira M; Scott CF; James A; Silver LD; Kueppers F; James HL; Colman RW
Biochemistry; 1982 Feb; 21(3):567-72. PubMed ID: 6175341
[No Abstract] [Full Text] [Related]
15. Computerized immunoblot analyses (CIBA) of the distribution of prekallikrein and its activation products in vivo and in vitro.
Veloso D; Campbell G
Agents Actions Suppl; 1992; 38 ( Pt 1)():166-73. PubMed ID: 1281607
[TBL] [Abstract][Full Text] [Related]
16. Chromogenic substrate assays for studying components of the plasma kallikrein system in health and disease.
Gallimore MJ
Adv Exp Med Biol; 1983; 156():225-31. PubMed ID: 6552839
[No Abstract] [Full Text] [Related]
17. Inhibition of human tissue kallikrein by alpha 1-proteinase inhibitor.
Hirano K; Okumura Y; Hayakawa S; Adachi T; Sugiura M
Hoppe Seylers Z Physiol Chem; 1984 Jan; 365(1):27-32. PubMed ID: 6201429
[TBL] [Abstract][Full Text] [Related]
18. Studies on plasma inhibitors of plasma kallikrein using chromogenic peptide substrate assays.
Gallimore MJ; Amundsen E; Larsbraaten M; Lyngaas K; Fareid E
Thromb Res; 1979; 16(5-6):695-703. PubMed ID: 93313
[No Abstract] [Full Text] [Related]
19. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
Czendlik C; Lämmle B; Duckert F
Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
[TBL] [Abstract][Full Text] [Related]
20. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
Schmaier AH; Gustafson E; Idell S; Colman RW
J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
